V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20216068 | 20082078 | 1.5 | 66 | Palliative (P) | 2017-03-27 | 2017-03-27 | LENVATINIB | 99 | N | LENVATINIB | 101611473 |
| 20216069 | 20082079 | 1.55 | 105.8 | Palliative (P) | 2017-07-31 | 2017-08-07 | null | null | N | CETUXIMAB + IRINOTECAN + MDG | 100222555 |
| 20216070 | 20082080 | 1.73 | 38.4 | Palliative (P) | null | 2018-12-08 | null | null | N | CETUXIMAB + IRINOTECAN + MDG | 100913970 |
| 20216075 | 20082082 | null | null | null | null | 2019-04-09 | null | null | null | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 101094289 |
| 20216076 | 20082083 | 1.56 | 51 | Curative (C) | 2018-09-15 | 2018-09-19 | CAPECITABINE + MITOMYCIN + RT | N | N | CAPECITABINE + MITOMYCIN + RT | 101327712 |
| 20216077 | 20082084 | 1.63 | 80 | Adjuvant (A) | 2019-03-04 | 2019-03-08 | Cisplatin + Etoposide (3 day) | 02 | N | CISPLATIN + ETOPOSIDE | 100836054 |
| 20216078 | 20082085 | null | 74.9 | Palliative (P) | 2018-09-04 | 2018-09-04 | LENVATINIB | 02 | N | LENVATINIB | 100030257 |
| 20216079 | 20082086 | 1.6 | 63.8 | Palliative (P) | 2017-11-16 | 2017-11-22 | Cape+Cisplatin+Trastuzumab Load | N | N | HCX | 101582057 |
| 20216080 | 20082087 | 1.55 | null | Neo-adjuvant (N) | null | 2017-07-09 | null | null | N | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 101491231 |
| 20216081 | 20082088 | 1.6 | 67.5 | Palliative (P) | 2019-08-12 | 2019-08-19 | null | null | N | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 101829848 |
| 20216082 | 20082089 | null | null | null | null | 2018-06-29 | null | null | null | CISPLATIN + ETOPOSIDE | 100772709 |
| 20216083 | 20082090 | null | null | null | null | 2020-04-04 | null | null | null | HCX | 100911880 |
| 20216084 | 20082091 | null | 72.1 | Palliative (P) | null | 2016-05-04 | null | null | null | CETUXIMAB + IRINOTECAN + MDG | 100742023 |
| 20216087 | 20082093 | 1.8 | 78.4 | Palliative (P) | null | 2018-01-07 | null | null | N | HCX | 100590458 |
| 20216091 | 20082094 | 1.76 | 71.8 | Curative (C) | 2020-02-14 | 2020-02-29 | null | null | Y | CAPECITABINE + IRINOTECAN | 101798830 |
| 20216094 | 20082096 | 1.8 | 106.8 | null | null | 2019-09-24 | null | null | N | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 101138290 |
| 20216095 | 20082097 | 1.77 | 38.4 | Palliative (P) | 2016-08-26 | 2016-08-28 | LENVATINIB | 02 | N | LENVATINIB | 101466376 |
| 20216096 | 20082098 | 1.68 | null | null | 2019-11-13 | 2019-11-13 | null | null | null | CAPECITABINE + IRINOTECAN | 100725403 |
| 20216097 | 20082099 | 1.77 | 69.9 | Neo-adjuvant (N) | null | 2020-04-23 | null | null | N | CETUXIMAB + IRINOTECAN + MDG | 100647320 |
| 20216098 | 20082100 | null | null | null | 2016-07-22 | 2016-09-02 | CAPECITABINE + IRINOTECAN | 1 | null | CAPECITABINE + IRINOTECAN | 100131665 |
| 20216099 | 20082101 | null | null | null | 2017-09-06 | 2017-09-20 | ECF | 02 | null | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100316929 |
| 20216100 | 20082102 | 1.73 | 78 | Palliative (P) | null | 2019-09-15 | null | null | N | HCX | 100476773 |
| 20216102 | 20082103 | 1.8 | 53.9 | Palliative (P) | null | 2019-10-04 | Capecitabine (21 day) + Irinotecan | N | N | CAPECITABINE + IRINOTECAN | 101712752 |
| 20216105 | 20082104 | 1.67 | 86.2 | Palliative (P) | 2018-07-19 | 2018-07-31 | CAPECITABINE + IRINOTECAN | 1 | N | CAPECITABINE + IRINOTECAN | 101121742 |
| 20216106 | 20082105 | 1.7 | 99.05 | Palliative (P) | 2019-02-26 | 2019-02-26 | ECarboX | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 100456039 |
| 20216107 | 20082106 | 1.7 | 90 | Curative (C) | null | 2016-08-16 | null | null | null | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100527088 |
| 20216108 | 20082107 | null | null | null | 2018-02-20 | 2018-03-20 | CAPECITABINE + MITOMYCIN + RT | N | null | CAPECITABINE + MITOMYCIN + RT | 101771280 |
| 20216109 | 20082108 | null | null | null | null | 2018-07-27 | null | null | null | HCX | 101378428 |
| 20216110 | 20082109 | null | null | null | null | 2020-01-26 | null | null | null | CAPECITABINE + IRINOTECAN | 100655310 |
| 20216111 | 20082110 | 1.7 | 103.5 | Palliative (P) | 2018-08-06 | 2018-08-07 | LENVATINIB | 02 | N | LENVATINIB | 101475900 |
| 20216112 | 20082111 | 1.65 | 64.6 | Palliative (P) | 2022-02-03 | 2022-02-10 | ECF | 02 | null | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 101423684 |
| 20216113 | 20082112 | null | null | null | 2017-11-28 | 2017-12-05 | null | null | null | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 101086273 |
| 20216114 | 20082113 | 1.7 | 81 | Palliative (P) | 2018-10-16 | 2018-11-12 | CAPECITABINE + MITOMYCIN + RT | N | N | CAPECITABINE + MITOMYCIN + RT | 101013378 |
| 20216115 | 20082114 | 0 | 60 | Palliative (P) | 2017-09-23 | 2017-09-23 | null | null | N | HCX | 100063477 |
| 20216118 | 20082117 | 1.66 | 105.8 | Neo-adjuvant (N) | 2016-12-17 | 2016-12-19 | ECF | null | N | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100744695 |
| 20216119 | 20082118 | 1.64 | 53.1 | Curative (C) | 2017-01-08 | 2017-01-12 | CETUXIMAB + IRINOTECAN + MDG | N | null | CETUXIMAB + IRINOTECAN + MDG | 101426372 |
| 20216123 | 20082120 | null | null | null | null | 2017-02-18 | null | null | null | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100591984 |
| 20216124 | 20082121 | null | null | null | 2016-01-28 | 2016-02-19 | null | null | null | HCX | 100590758 |
| 20216125 | 20082122 | null | null | null | 2020-01-28 | 2020-02-04 | Cisplatin + Etoposide (3 day) | 02 | null | CISPLATIN + ETOPOSIDE | 101275877 |
| 20216127 | 20082123 | 1.53 | 60.9 | Palliative (P) | null | 2016-12-16 | null | null | N | LENVATINIB | 101636450 |
| 20216128 | 20082124 | null | null | null | null | 2019-08-10 | null | null | null | CAPECITABINE + IRINOTECAN | 101320045 |
| 20216129 | 20082125 | 1.53 | 77.9 | Palliative (P) | 2017-02-22 | 2017-02-25 | null | null | Y | CETUXIMAB + IRINOTECAN + MDG | 100978462 |
| 20216130 | 20082126 | null | null | null | 2018-01-29 | 2018-01-29 | CETUXIMAB + IRINOTECAN + MDG | N | null | CETUXIMAB + IRINOTECAN + MDG | 101029398 |
| 20216132 | 20082128 | 1.49 | 73 | Adjuvant (A) | 2017-07-18 | 2017-07-19 | Cetuximab + FOLFIRI cycle 2 onwards | N | Y | CETUXIMAB + IRINOTECAN + MDG | 101680584 |
| 20216133 | 20082129 | 1.72 | 86.8 | null | 2020-01-21 | 2020-01-26 | ECF | null | null | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100076084 |
| 20216134 | 20082130 | 1.71 | 81.8 | null | null | 2019-10-03 | null | null | null | CAPECITABINE + MITOMYCIN + RT | 101682919 |
| 20216137 | 20082132 | 1.82 | null | Neo-adjuvant (N) | null | 2017-11-27 | null | null | N | CETUXIMAB + IRINOTECAN + MDG | 100008737 |
| 20216139 | 20082133 | 1.7 | 55 | 03 | 2016-03-03 | 2016-03-13 | Capecitabine (14 day) + Irinotecan | 02 | N | CAPECITABINE + IRINOTECAN | 101865538 |
| 20216142 | 20082135 | null | null | null | 2018-09-29 | 2018-10-10 | null | null | null | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100069535 |
| 20216143 | 20082136 | null | null | null | 2019-09-24 | 2019-09-30 | null | null | null | CETUXIMAB + IRINOTECAN + MDG | 101243041 |